Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lia Gore

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Best Practice & Research. Clinical Haematology|December 14, 2022
What are the long-term complications of pediatric ALL treatments and how can they be mitigated? Perspectives on long-term consequences of curative treatment in childhood ALLLia Gore
Clinical Advances in Hematology & Oncology : H&O|July 28, 2017
Drug development for rare cancers in childrenLia Gore
Expert Opinion on Investigational Drugs|September 6, 2011
Entinostat for treatment of solid tumors and hematologic malignanciesJeffrey Knipstein, Lia Gore
Hematology. American Society of Hematology. Education Program|December 7, 2019
Moving immunotherapy into the front line in ALLAmanda Winters, Lia Gore
Pediatric Blood & Cancer|July 11, 2023
Children's Oncology Group's 2023 blueprint for researchDouglas S Hawkins, Lia Gore
Frontiers in Oncology|April 19, 2014
Blinatumomab, a Bi-Specific Anti-CD19/CD3 BiTE(®) Antibody for the Treatment of Acute Lymphoblastic Leukemia: Perspectives and Current Pediatric ApplicationsLindsey M Hoffman, Lia Gore
Haematologica|June 4, 2024
Bispecific T-cell engagers in childhood B-acute lymphoblastic leukemiaKaylyn Utley Lyons, Lia Gore
Blood|January 28, 2021
Eliminating disparities improves outcomesLia Gore, Amy K Keating
Cell|March 29, 2024
Only the beginning: 50 years of progress toward curing childhood cancerLia Gore, Maureen M O'Brien
Current Hematologic Malignancy Reports|July 20, 2010
Emerging non-transplant-based strategies in treating pediatric non-Hodgkin's lymphomaLia Gore, Tanya M Trippett
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Best Practice & Research. Clinical Haematology|December 14, 2022
What are the long-term complications of pediatric ALL treatments and how can they be mitigated? Perspectives on long-term consequences of curative treatment in childhood ALLLia Gore
Clinical Advances in Hematology & Oncology : H&O|July 28, 2017
Drug development for rare cancers in childrenLia Gore
Expert Opinion on Investigational Drugs|September 6, 2011
Entinostat for treatment of solid tumors and hematologic malignanciesJeffrey Knipstein, Lia Gore
Hematology. American Society of Hematology. Education Program|December 7, 2019
Moving immunotherapy into the front line in ALLAmanda Winters, Lia Gore
Pediatric Blood & Cancer|July 11, 2023
Children's Oncology Group's 2023 blueprint for researchDouglas S Hawkins, Lia Gore
Frontiers in Oncology|April 19, 2014
Blinatumomab, a Bi-Specific Anti-CD19/CD3 BiTE(®) Antibody for the Treatment of Acute Lymphoblastic Leukemia: Perspectives and Current Pediatric ApplicationsLindsey M Hoffman, Lia Gore
Haematologica|June 4, 2024
Bispecific T-cell engagers in childhood B-acute lymphoblastic leukemiaKaylyn Utley Lyons, Lia Gore
Blood|January 28, 2021
Eliminating disparities improves outcomesLia Gore, Amy K Keating
Cell|March 29, 2024
Only the beginning: 50 years of progress toward curing childhood cancerLia Gore, Maureen M O'Brien
Current Hematologic Malignancy Reports|July 20, 2010
Emerging non-transplant-based strategies in treating pediatric non-Hodgkin's lymphomaLia Gore, Tanya M Trippett
Pageof 14